Related Experiment Video
Updated: Aug 6, 2026

A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery
Published on: January 18, 2018
Control of oncologic pain in relief of suffering. Our experience
M González Barón1, M A Lacasta Reverte, A Ordóñez Gallego
1Cathedra of Medical Oncology and Palliative Medicine, Medical Oncology Division, Hospital Universitario La Paz, Universidad Autonoma de Madrid. mgonzalezb.hulp@salud.madrid.org
Background:
Pain and suffering are not synonymous terms. The concept of suffering is wider than just physical pain. People can suffer for multiple causes, pain among them, but it is not the only reason since <
Aims:
The main objectives of our work were: First: to evaluate the efficacy of a tool that allows the identification of the symptoms perceived by the patient as a threat in order to reduce or suppress them and empower their resources at the same time; and secondly to evaluate the incidence of pain in the suffering.
Materials And Methods:
Our tool includes the following groups of variables: subjective perception of the time course, emotional aspects, concerns and confrontation strategies, perception of adaptation and sense of life, perceived support and pain. This tool has been tested in 73 oncologic patients, 31 men and 42 women, mean aged 55, 41 (SD = 14, 54) visited at the Medical Oncology Service of La Paz Hospital.
Results:
Mainly, people who refers great suffering are those with more pain (p < 0.05); while patients with less suffering and higher well-being are those that use strategies to face their situation (p < 0.05). Our tool reduces perceived threats and that reflects the need for a good control of pain and at the same time to empower the resources to relieve the suffering as much as possible.
Conclusion:
The referred tool seems to be effective in order to easy the intervention to relieve the suffering.
Related Concept Videos
Analgesia and Pain Management
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Pain
Nociception
Continuing Care
Tumor Immunotherapy
